Navigation Links
Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin
Date:11/6/2008

and retain key personnel; changes in technology, government regulation and general market conditions; and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K for the year ended December 31, 2007 and its Quarterly Report on Form 10-Q for the period ended September 30, 2008, which will be filed with the SEC on or about November 7, 2008. Readers are cautioned not to place undue reliance on these forward- looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update any forward-looking statement to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.

(C) 2008 Poniard Pharmaceuticals, Inc. All Rights Reserved. Poniard and Poniard Pharmaceuticals are trademarks of Poniard Pharmaceuticals, Inc.


'/>"/>
SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Diseases largely eradicated in the ... Measles was declared eliminated in 2000, yet the CDC ... 15—the highest incidence in 20 years. In July, ... cough a problem of "epidemic proportions." ... from these preventable diseases—in part because some parents (more ...
(Date:8/29/2014)...  In part four of a blog ... as a strategic asset, Mary Baxter, MBA, RPh ... Health,s Innovation Delivery Solutions business, discusses how expanding patient ... and patients. "Every hospital pharmacist knows that ... job in a value-based healthcare world," Baxter says. "For ...
(Date:8/29/2014)... -- Pixcelldata, the innovative Irish developer of ... major new deal with Dutch based eX-Path, global providers ... Marius Nap . The announcement was ... Pathology which is taking placing between August 30th and ... where Pixcelldata will demonstrate its innovative solution. ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2
... , LONDON and PHILADELPHIA, Dec. 11 ... form of breast cancer experienced a median survival of 14 ... plus HERCEPTIN® (trastuzumab). The results of the Phase III study ... Annual CTRC-AACR San Antonio Breast Cancer Symposium, held in San ...
... , , BATESVILLE, Ind., ... introduction of Hill-Rom,s Advanta(TM) 2 Bed for use in medical-surgical areas of ... with key safety features and the flexibility to use a variety of ... new solution to our customers. It combines the best features of Hill-Rom,s ...
Cached Medicine Technology:GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 2GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 3GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 4GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 5GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 6Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 2Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 3Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 4
(Date:8/29/2014)... 2014 Floors of hospitals and other ... socks. Also, many patients are relegated to lying down ... recovery, Alzheimer’s, etc. Two inventors from Perrysburg, Ohio, have ... safety. , This special pair of socks helps prevent ... patients who are relegated to beds or chairs from ...
(Date:8/29/2014)... Francisco, CA (PRWEB) August 30, 2014 ... 10 best web conference providers in the online service ... the list were global leaders Webex, GotoMeeting and Infinite. ... the industry users have to determine which provider is ... Essentially, web conference businesses search for compelling consumer goods ...
(Date:8/29/2014)... by volunteering are getting more out of it than ... health boost! , A new study, led ... and published online this week in Psychological Bulletin ... at all the available peer-reviewed evidence regarding the psychosocial ... Lead investigator Dr. Nicole Anderson, together with scientists from ...
(Date:8/29/2014)... 29, 2014 University of Western States ... professionals, announced that Daniel Redwood, DC, director of the ... of the Year,” by the Missouri State Chiropractors Association ... 21. , Patrick Montgomery, DC, president of the MSCA, ... the Missouri House Task Force for Medicaid Reform, in ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Evolutions Medical ... Barbara in the Santa Barbara News-Press Readers’ Choice 2014 ... the Readers’ Choice poll as Best Medical Spa. The ... reads the following about Evolutions Medical Spa recognition: , ... it is recognized as a top-notch, cutting-edge medical spa ...
Breaking Medicine News(10 mins):Health News:Top10InAction Reveals Best Web Conference Providers 2Health News:Evidence mounting that older adults who volunteer are happier, healthier 2Health News:University of Western States Director of Human Nutrition and Functional Medicine Daniel Redwood, DC, named Missouri Educator of the Year by MSCA 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 3
... who received testosterone supplementation increased lean body mass and decreased ... in mobility or cognition compared with men who did not ... 2 issue of JAMA. , Male aging is associated ... testosterone, occurring to a greater extent in some men than ...
... prevalent than thought. However, when they do exist, nightmares ... as early as five months, according to a study published ... The study, led by Valrie Simard, under the direction of ... children in the Province of Quebec, who were assessed by ...
... A study published in the January 1 issue of ... taken three to seven nights per week for up ... sleep onset and maintenance, and also improved next-day concentration ... study focused on 1,018 patients between 18 and 64 ...
... tonsillitis substantially improve a patients quality of live in ... published as a supplement to the January 2008 issue ... involving 72 adults, patients showed improvement in all six ... (TAHSI), a scale used to measure the quality of ...
... that treat depression, schizophrenia and other psychotic conditions and ... not be triggering the most appropriate response in those ... The Ohio State University Medical Center examined the serotonin ... the neurotransmitter serotonin. , This study examined the early ...
... seek out support from friends, experts advise , , MONDAY, Dec. ... 50 will resolve to start a new fitness program. , ... for helping to keep that resolve: , Get a ... exercise program and to find out if you need to ...
Cached Medicine News:Health News:Testosterone supplementation for older men appears to have limited benefit 2Health News:Preschoolers' nightmares less prevalent, are trait-like and associated with personality 2Health News:Preschoolers' nightmares less prevalent, are trait-like and associated with personality 3Health News:Journal Sleep: A short-term dose of zolpidem is an effective treatment for insomnia 2Health News:Some antipsychotic drugs may be missing their mark 2Health News:Make That New Year's Fitness Resolution Stick 2
... 25,000 units Penicillin/25,000 ... Cell Culture Reagent and ... in accordance with cGMP ... culture tested to assure ...
Penicillin-Streptomycin-Glutamine (100X) liquid...
Penicillin-Streptomycin liquid...
... combination of penicillin and streptomycin which ... and gram negative bacteria when used ... I.U. Penicillin/100,000 g/mL Streptomycin per liter. ... water at concentrations of 5,000 I.U. ...
Medicine Products: